Jun Ma

Person

Belmont, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 12,018,017
- Issue date Jun 25, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Spiropyrrolidine derived antiviral agents
- Patent number 11,976,084
- Issue date May 7, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitor...
- Patent number 11,834,436
- Issue date Dec 5, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 11,560,368
- Issue date Jan 24, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoxazole derivatives as FXR agonists and methods of use thereof
- Patent number 11,555,032
- Issue date Jan 17, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Spiropyrrolidine derived antiviral agents
- Patent number 11,384,090
- Issue date Jul 12, 2022
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 11,345,699
- Issue date May 31, 2022
- Enanta Pharmaceuticals, Inc.
- Brett Granger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoxazole analogs as FXR agonists and methods of use thereof
- Patent number 11,034,684
- Issue date Jun 15, 2021
- Enanta Pharmaceuticals, Inc.
- Jun Ma
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitor...
- Patent number 11,008,304
- Issue date May 18, 2021
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 10,988,458
- Issue date Apr 27, 2021
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoxazole derivatives as FXR agonists and methods of use thereof
- Patent number 10,829,486
- Issue date Nov 10, 2020
- Enanta Pharmacueticals, Inc.
- Ruichao Shen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isoxazole analogs as FXR agonists and methods of use thereof
- Patent number 10,689,391
- Issue date Jun 23, 2020
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 10,683,279
- Issue date Jun 16, 2020
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Urea-containing isoxazole derivatives as FXR agonists and methods o...
- Patent number 10,597,391
- Issue date Mar 24, 2020
- Enanta Pharmaceuticals, Inc.
- Jing He
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 10,450,301
- Issue date Oct 22, 2019
- Enanta Pharmaceuticals, Inc.
- Brett Granger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoxazole analogs as FXR agonists and methods of use thereof
- Patent number 10,450,306
- Issue date Oct 22, 2019
- Enanta Pharmaceuticals, Inc.
- Jun Ma
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 10,253,018
- Issue date Apr 9, 2019
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 10,246,439
- Issue date Apr 2, 2019
- Enanta Pharmaceuticals, Inc.
- Brett Granger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoxazole derivatives as FXR agonists and methods of use thereof
- Patent number 10,149,835
- Issue date Dec 11, 2018
- Elmore Patent Law Group, P.C.
- Yat Sun Or
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isoxazole analogs as FXR agonists and methods of use thereof
- Patent number 10,144,729
- Issue date Dec 4, 2018
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoxazole derivatives as FXR agonists and methods of use therof
- Patent number 10,138,228
- Issue date Nov 27, 2018
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoxazole derivatives as FXR agonists and methods of use thereof
- Patent number 10,080,741
- Issue date Sep 25, 2018
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isoxazole derivatives as FXR agonists and methods of use thereof
- Patent number 10,080,743
- Issue date Sep 25, 2018
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isoxazole derivatives as FXR agonists and methods of use thereof
- Patent number 10,080,742
- Issue date Sep 25, 2018
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
5, 6-D2 uridine nucleoside/tide derivatives
- Patent number 10,034,893
- Issue date Jul 31, 2018
- Enanta Pharmaceuticals, Inc.
- Jay R. Luly
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Macrocyclic proline derived HCV serine protease inhibitors
- Patent number 9,220,748
- Issue date Dec 29, 2015
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2′allene-substituted nucleoside derivatives
- Patent number 9,085,599
- Issue date Jul 21, 2015
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Macrocyclic nucleoside phosphoramidate derivatives
- Patent number 8,846,638
- Issue date Sep 30, 2014
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Macrocyclic proline derived HCV serine protease inhibitors
- Patent number 8,648,037
- Issue date Feb 11, 2014
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Apoptosis Signal-Regulating Kinase 1 Inhibitors and Methods of Use...
- Publication number 20240376079
- Publication date Nov 14, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...
- Publication number 20240228464
- Publication date Jul 11, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...
- Publication number 20240132476
- Publication date Apr 25, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIMIDINONE-CONTAINING 17-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1...
- Publication number 20230416268
- Publication date Dec 28, 2023
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- C07 - ORGANIC CHEMISTRY
Information Patent Application
APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...
- Publication number 20230174515
- Publication date Jun 8, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
17-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 13 INHIBITORS AND METHODS...
- Publication number 20230143250
- Publication date May 11, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS
- Publication number 20230103494
- Publication date Apr 6, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...
- Publication number 20220356167
- Publication date Nov 10, 2022
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS
- Publication number 20220162216
- Publication date May 26, 2022
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS
- Publication number 20220162231
- Publication date May 26, 2022
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...
- Publication number 20220119366
- Publication date Apr 21, 2022
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF
- Publication number 20200361920
- Publication date Nov 19, 2020
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...
- Publication number 20200331890
- Publication date Oct 22, 2020
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS
- Publication number 20200270303
- Publication date Aug 27, 2020
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...
- Publication number 20200157095
- Publication date May 21, 2020
- Enanta Pharmaceuticals, Inc.
- Brett Granger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ISOXAZOLE ANALOGS AS FXR AGONISTS AND METHODS OF USE THEREOF
- Publication number 20200079764
- Publication date Mar 12, 2020
- Enanta Pharmaceuticals, Inc.
- Jun Ma
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...
- Publication number 20190337923
- Publication date Nov 7, 2019
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS
- Publication number 20190263860
- Publication date Aug 29, 2019
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF
- Publication number 20190248777
- Publication date Aug 15, 2019
- Enanta Pharmaceuticals, Inc.
- Ruichao Shen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ISOXAZOLE ANALOGS AS FXR AGONISTS AND METHODS OF USE THEREOF
- Publication number 20190194216
- Publication date Jun 27, 2019
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Apoptosis Signal-Regulating Kinase 1 Inhibitors and Methods of Use...
- Publication number 20180362501
- Publication date Dec 20, 2018
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...
- Publication number 20180362502
- Publication date Dec 20, 2018
- Enanta Pharmaceuticals, Inc.
- Brett Granger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...
- Publication number 20180362503
- Publication date Dec 20, 2018
- Enanta Pharmaceuticals, Inc.
- Brett Granger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...
- Publication number 20180327388
- Publication date Nov 15, 2018
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS
- Publication number 20180162905
- Publication date Jun 14, 2018
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
UREA-CONTAINING ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS O...
- Publication number 20180141941
- Publication date May 24, 2018
- Enanta Pharmaceuticals, Inc.
- Jing He
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ISOXAZOLE ANALOGS AS FXR AGONISTS AND METHODS OF USE THEREOF
- Publication number 20180099957
- Publication date Apr 12, 2018
- Enanta Pharmaceuticals, Inc.
- Jun Ma
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Isoxazole Derivatives as FXR Agonists and Methods of Use Thereof
- Publication number 20170334894
- Publication date Nov 23, 2017
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Isoxazole Derivatives as FXR Agonists and Methods of Use Thereof
- Publication number 20170333399
- Publication date Nov 23, 2017
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Isoxazole Analogs as FXR Agonists and Methods of Use Thereof
- Publication number 20170334893
- Publication date Nov 23, 2017
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- C07 - ORGANIC CHEMISTRY

Person

Patents Grantslast 30 patents

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Spiropyrrolidine derived antiviral agents

Tetrazole containing apoptosis signal-regulating kinase 1 inhibitor...

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Isoxazole derivatives as FXR agonists and methods of use thereof

Spiropyrrolidine derived antiviral agents

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Isoxazole analogs as FXR agonists and methods of use thereof

Tetrazole containing apoptosis signal-regulating kinase 1 inhibitor...

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Isoxazole derivatives as FXR agonists and methods of use thereof

Isoxazole analogs as FXR agonists and methods of use thereof

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Urea-containing isoxazole derivatives as FXR agonists and methods o...

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Isoxazole analogs as FXR agonists and methods of use thereof

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Isoxazole derivatives as FXR agonists and methods of use thereof

Isoxazole analogs as FXR agonists and methods of use thereof

Isoxazole derivatives as FXR agonists and methods of use therof

Isoxazole derivatives as FXR agonists and methods of use thereof

Isoxazole derivatives as FXR agonists and methods of use thereof

Isoxazole derivatives as FXR agonists and methods of use thereof

5, 6-D2 uridine nucleoside/tide derivatives

Macrocyclic proline derived HCV serine protease inhibitors

2′allene-substituted nucleoside derivatives

Macrocyclic nucleoside phosphoramidate derivatives

Macrocyclic proline derived HCV serine protease inhibitors

Patents Applicationslast 30 patents

Apoptosis Signal-Regulating Kinase 1 Inhibitors and Methods of Use...

TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...

TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...

PYRIMIDINONE-CONTAINING 17-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1...

APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...

17-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 13 INHIBITORS AND METHODS...

NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS

APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...

NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS

NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS

TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...

ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF

APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...

MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS

APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...

ISOXAZOLE ANALOGS AS FXR AGONISTS AND METHODS OF USE THEREOF

TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...

MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS

ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF

ISOXAZOLE ANALOGS AS FXR AGONISTS AND METHODS OF USE THEREOF

Apoptosis Signal-Regulating Kinase 1 Inhibitors and Methods of Use...

APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...

APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...

APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...

MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS

UREA-CONTAINING ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS O...

ISOXAZOLE ANALOGS AS FXR AGONISTS AND METHODS OF USE THEREOF

Isoxazole Derivatives as FXR Agonists and Methods of Use Thereof

Isoxazole Derivatives as FXR Agonists and Methods of Use Thereof

Isoxazole Analogs as FXR Agonists and Methods of Use Thereof